Zobrazeno 1 - 10
of 393
pro vyhledávání: '"silke gillessen"'
Autor:
Stefanie Fischer, Silke Gillessen, Odile Stalder, Angelika Terbuch, Richard Cathomas, Florian A. Schmid, Deborah Zihler, Beat Müller, Christian D. Fankhauser, Anita Hirschi-Blickenstorfer, Luis Alex Kluth, Bettina Seifert, Arnoud J. Templeton, Walter Mingrone, Mark-Peter Ufe, Natalie Fischer, Jörg Beyer, Regina Woelky, Aurelius Omlin, Ursula Vogl, Katharina Hoppe, Jörn Kamradt, Sacha I. Rothschild, Christian Rothermundt
Publikováno v:
European Urology Open Science, Vol 68, Iss , Pp 68-74 (2024)
Background and objective: Follow-up for patients with testicular cancer should ensure early detection of relapses. Optimal schedules and minimum requirements for cross-sectional imaging are not clearly defined, and guideline recommendations differ. O
Externí odkaz:
https://doaj.org/article/cf3f1f7b4c80443686e599e578c8dbdd
Autor:
Giuseppe Salfi, Martino Pedrani, Selin Candan, Vasile Urechie, Sara Merler, Lorenzo Ruinelli, Amos Colombo, Luis Castelo-Branco, Irene Testi, Fabio Turco, Luigi Tortola, Ursula Vogl, Luca Gabutti, Silke Gillessen, Ricardo Pereira Mestre
Publikováno v:
European Urology Open Science, Vol 71, Iss , Pp 1-10 (2025)
Background and objective: Hypertension (HTN) has been linked to an elevated risk of prostate cancer (PC) development and poorer prognosis in localized cases, and is a common side effect of hormonal PC treatments. However, its relationship with the pr
Externí odkaz:
https://doaj.org/article/bef17657e48c4a8fb39ac7218bd8d552
Autor:
Guillaume Grisay, Fabio Turco, Saskia Litiere, Béatrice Fournier, Anna Patrikidou, Enrique Gallardo, Ray McDermott, Ahu Alanya, Silke Gillessen, Bertrand Tombal
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The landscape of treating metastatic prostate cancer has evolved with the addition of Androgen Receptor pathway inhibitor (ARPI) to Androgen Deprivation Therapy (ADT), significantly improving survival rates. However, prolonged use of these therapies
Externí odkaz:
https://doaj.org/article/81835467e73e4364af4a30938a8d05b9
Autor:
Christian D. Fankhauser, Abolghassem Jandari, Laurence Collette, Torgrim Tandstad, Di Maria Jiang, Ugo De Giorgi, Christopher Sweeney, Angelika Terbuch, Michal Chovanec, Robert Huddart, Carsten Bokemeyer, Jörg Beyer, Silke Gillessen
Publikováno v:
European Urology Open Science, Vol 56, Iss , Pp 25-28 (2023)
Levels of the serum tumor markers (STMs) α-fetoprotein, human chorionic gonadotropin, and lactate dehydrogenase are used in staging classification for metastatic germ-cell cancers and support decisions on the intensity of first-line treatment for pa
Externí odkaz:
https://doaj.org/article/728c03a8fee14e1194b055c2b8c9971a
Autor:
Stefanie Fischer, Christian Rothermundt, Odile Stalder, Angelika Terbuch, Thomas Hermanns, Deborah Zihler, Beat Müller, Christian D. Fankhauser, Anita Hirschi-Blickenstorfer, Bettina Seifert, Luis Alex Kluth, Mark-Peter Ufe, Walter Mingrone, Arnoud J. Templeton, Natalie Fischer, Sacha Rothschild, Regina Woelky, Silke Gillessen, Richard Cathomas
Publikováno v:
European Urology Open Science, Vol 50, Iss , Pp 57-60 (2023)
The tumour markers alpha-fetoprotein (AFP), beta human chorionic gonadotropin (βHCG), and lactate dehydrogenase (LDH) have established roles in the management and follow-up of testicular cancer. While a tumour marker rise can serve as an indicator o
Externí odkaz:
https://doaj.org/article/6b392f93b5874dadb0ac979caa21880c
Autor:
Ernest Kaufmann, Luca Antonelli, Peter Albers, Clint Cary, Silke Gillessen Sommer, Axel Heidenreich, Christoph Oing, Jan Oldenburg, Phillip Martin Pierorazio, Andrew J. Stephenson, Christian Daniel Fankhauser
Publikováno v:
European Urology Open Science, Vol 44, Iss , Pp 142-149 (2022)
Context: The aim of this review is to describe the proportion of testicular germ cell tumours (tGCTs) with recurrence, and the timing and anatomical sites of relapse across different disease stages and after different treatment options. We summarise
Externí odkaz:
https://doaj.org/article/119c9042f3b74cbc9fc9c02f59deef98
Autor:
Arnoud J. Templeton, Aurelius Omlin, Dominik Berthold, Jörg Beyer, Irene A. Burger, Daniel Eberli, Daniel Engeler, Christian Fankhauser, Stefanie Fischer, Silke Gillessen, Guillaume Nicolas, Stephanie Kroeze, Anja Lorch, Michael Müntener, Alexandros Papachristofilou, Niklaus Schaefer, Daniel Seiler, Frank Stenner, Petros Tsantoulis, Tatjana Vlajnic, Thomas Zilli, Daniel Zwahlen, Richard Cathomas
Publikováno v:
Swiss Medical Weekly, Vol 153, Iss 8 (2023)
The management of prostate cancer is undergoing rapid changes in all disease settings. Novel imaging tools for diagnosis have been introduced, and the treatment of high-risk localized, locally advanced and metastatic disease has changed considerably
Externí odkaz:
https://doaj.org/article/253dd9f4666147ea9d85f1bee5fa5a4c
Autor:
Antonio Rodriguez-Calero, John Gallon, Dilara Akhoundova, Sina Maletti, Alison Ferguson, Joanna Cyrta, Ursula Amstutz, Andrea Garofoli, Viola Paradiso, Scott A. Tomlins, Ekkehard Hewer, Vera Genitsch, Achim Fleischmann, Erik Vassella, Elisabeth J. Rushing, Rainer Grobholz, Ingeborg Fischer, Wolfram Jochum, Gieri Cathomas, Adeboye O. Osunkoya, Lukas Bubendorf, Holger Moch, George Thalmann, Charlotte K. Y. Ng, Silke Gillessen, Salvatore Piscuoglio, Mark A. Rubin
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
The diagnosis of prostate cancer brain metastasis (PCBM) has increased. Here, the authors investigate the landscape of somatic genetic alterations in brain metastases in a PCBM cohort of 51 patients with non-synchronous matched primary samples availa
Externí odkaz:
https://doaj.org/article/42966ddd44de4ed4a87861f3d4c3176c
Autor:
Marco Bolis, Daniela Bossi, Arianna Vallerga, Valentina Ceserani, Manuela Cavalli, Daniela Impellizzieri, Laura Di Rito, Eugenio Zoni, Simone Mosole, Angela Rita Elia, Andrea Rinaldi, Ricardo Pereira Mestre, Eugenia D’Antonio, Matteo Ferrari, Flavio Stoffel, Fernando Jermini, Silke Gillessen, Lukas Bubendorf, Peter Schraml, Arianna Calcinotto, Eva Corey, Holger Moch, Martin Spahn, George Thalmann, Marianna Kruithof-de Julio, Mark A. Rubin, Jean-Philippe P. Theurillat
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Transcriptional changes during prostate cancer progression are not yet fully understood. Here, the authors integrate a transcriptomics atlas of prostate cancer and validate it with preclinical models and single-cell RNA-seq, revealing the role of EZH
Externí odkaz:
https://doaj.org/article/6a080edb8c7340f18674ce8c5a8eaff3
Autor:
Fernando Cotait Maluf, Felipe Moraes Toledo Pereira, Pedro Luiz Serrano Uson, Diogo Assed Bastos, Diogo Augusto Rodrigues da Rosa, Evanius Garcia Wiermann, Fábio A. Schutz, Fábio Roberto Kater, Fernando Nunes Galvão de Oliveira, Fernando Sabino Marques Monteiro, Fernando Vidigal de Pádua, Francisco Javier Orlandi, Helena Paes de Almeida Saito, Mouna Ayadi, Pamela Salman Boghikian, Ray Manneh Kopp, Ricardo Saraiva de Carvalho, Rodrigo Nogueira de Fogace, Sandro Roberto de Araújo Cavallero, Sergio Aguiar, Vinicius Carreira Souza, Silke Gillessen Sommer
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 550-558 (2021)
PURPOSEInternational guideline recommendations may not always be extrapolated to developing countries where access to resources is limited. In metastatic castration-sensitive prostate cancer (mCSPC), there have been successful drug and imaging advanc
Externí odkaz:
https://doaj.org/article/2909ca2cf77c40b09f9205eded36ee7f